ST GALLEN, Switzerland & STAMFORD, Conn. — (BUSINESS WIRE) — Regulatory News: This press release features multimedia. View the full release here: https://www.businesswire.com/news/h…
VFMCRP and Cara Therapeutics announce positive results from global KALM-2 pivotal phase-III trial of KORSUVA™ injection in haemodialysis patients with Pruritus
ST GALLEN, Switzerland & STAMFORD, Conn. — (BUSINESS WIRE) — Regulatory News: This press release features multimedia. View the full release here: https://www.businesswire.com/news/h…